Swiss National Bank Clovis Oncology, Inc. Transaction History

Swiss National Bank

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.63 - $2.96 $183,897 - $864,024	-291,900 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$1.43 - $3.14 $63,492 - $139,416	44,400 Added 17.94%	291,900 $590,000
Q4 2021 Feb 08, 2022	BUY	$2.7 - $4.76 $77,220 - $136,136	28,600 Added 13.07%	247,500 $671,000
Q2 2021 Aug 06, 2021	BUY	$5.02 - $7.05 $136,544 - $191,760	27,200 Added 14.19%	218,900 $1.27 Million
Q1 2021 May 07, 2021	BUY	$4.81 - $10.34 $24,530 - $52,734	5,100 Added 2.73%	191,700 $1.35 Million
Q2 2020 Aug 05, 2020	BUY	$5.69 - $9.69 $1.06 Million - $1.81 Million	186,600 New	186,600 $1.26 Million
Q4 2019 Feb 06, 2020	SELL	$3.0 - $16.43 $250,650 - $1.37 Million	-83,550 Closed	0 $0
Q2 2019 Aug 02, 2019	SELL	$12.81 - $25.67 $98,637 - $197,659	-7,700 Reduced 8.44%	83,550 $1.24 Million
Q1 2019 May 10, 2019	BUY	$17.66 - $30.28 $49,448 - $84,784	2,800 Added 3.17%	91,250 $2.27 Million
Q4 2018 Feb 13, 2019	BUY	$11.63 - $32.67 $16,282 - $45,738	1,400 Added 1.61%	88,450 $1.59 Million
Q3 2018 Nov 08, 2018	BUY	$29.37 - $49.48 $99,858 - $168,232	3,400 Added 4.06%	87,050 $2.56 Million
Q2 2018 Aug 09, 2018	BUY	$42.06 - $62.4 $117,768 - $174,720	2,800 Added 3.46%	83,650 $3.8 Million
Q1 2018 May 04, 2018	BUY	$50.12 - $67.72 $90,216 - $121,896	1,800 Added 2.28%	80,850 $4.27 Million
Q4 2017 Feb 07, 2018	BUY	$57.69 - $84.58 $149,994 - $219,908	2,600 Added 3.4%	79,050 $5.38 Million
Q3 2017 Nov 03, 2017	BUY	$67.17 - $84.81 $5.14 Million - $6.48 Million	76,450	76,450 $6.3 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.